Work

First-in-human study of AMG 337, a highly selective oral inhibitor of MET, in adult patients (pts) with advanced solid tumors.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2508

Authors: David S. Hong, Patricia LoRusso, Omid Hamid, Darrin M. Beaupre, Filip Janku, Rabia Khan, Muaiad Kittaneh, Robert D. Loberg, Benny Amore, Isaac Caudillo, Yuying C. Hwang, Rui Tang, Gataree Ngarmchamnanrith, Eunice Lee Kwak

Institutions: The University of Texas MD Anderson Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Angeles Clinic and Research Institute, Pharmacyclics (United States), Amgen (United States), Massachusetts General Hospital

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601712675

Cites:

Cited by: 28

Related to: 10